HIV-1 gp41 and TCRalpha trans-membrane domains share a motif exploited by the HIV virus to modulate T-cell proliferation.
Viruses have evolved several strategies to modify cellular processes and evade the immune response in order to successfully infect, replicate, and persist in the host. By utilizing in-silico testing of a transmembrane sequence library derived from virus protein sequences, we have pin-pointed a nine amino-acid motif shared by a group of different viruses; this motif resembles the transmembrane domain of the alpha-subunit of the T-cell receptor (TCRalpha). The most striking similarity was found within the immunodeficiency virus (SIV and HIV) glycoprotein 41 TMD (gp41 TMD). Previous studies have shown that stable interactions between TCRalpha and CD3 are localized to this nine amino acid motif within TCRalpha, and a peptide derived from it (TCRalpha TMD, GLRILLLKV) interfered and intervened in the TCR function when added exogenously. We now report that the gp41 TMD peptide co-localizes with CD3 within the TCR complex and inhibits T cell proliferation in vitro. However, the inhibitory mechanism of gp41 TMD differs from that of the TCRalpha TMD and also from the other two known immunosuppressive regions within gp41.
Cohen
Tomer
T
Department of Biological Chemistry, Weizmann Institute of Science, Rehovot, Israel.
Cohen
Shmuel Jaffe
SJ
Antonovsky
Niv
N
Cohen
Irun R
IR
Shai
Yechiel
Y
D000818:Animals; D017252:CD3 Complex / Q000378:metabolism; D019295:Computational Biology; D004735:Energy Transfer; D015700:HIV Envelope Protein gp41 / Q000235:genetics / Q000378:metabolism*; D015658:HIV Infections / Q000378:metabolism*; D015497:HIV-1 / Q000276:immunology / Q000472:pathogenicity*; D006801:Humans; D015759:Ionomycin / Q000494:pharmacology; D007476:Ionophores / Q000494:pharmacology; D008213:Lymphocyte Activation / Q000187:drug effects; D051379:Mice; D008810:Mice, Inbred C57BL; D010446:Peptide Fragments / Q000378:metabolism; D017434:Protein Structure, Tertiary; D011948:Receptors, Antigen, T-Cell / Q000235:genetics / Q000378:metabolism*; D013601:T-Lymphocytes / Q000166:cytology* / Q000276:immunology / Q000378:metabolism*
D017252:CD3 Complex; D015700:HIV Envelope Protein gp41; D007476:Ionophores; D010446:Peptide Fragments; D011948:Receptors, Antigen, T-Cell; C514787:gp41 protein, Human immunodeficiency virus 1; D015759:Ionomycin
Immunity. 2006 May;24(5):547-61
16713973
Cell Immunol. 2002 Jan;215(1):12-9
12142032
J Virol. 1989 Aug;63(8):3257-60
2526228
Eur J Immunol. 2006 Jul;36(7):1654-8
16791883
Immunity. 2001 Jun;14(6):763-77
11420046
Biochem J. 1990 Dec 15;272(3):713-9
2176475
J Exp Med. 1993 Mar 1;177(3):717-27
7679708
FASEB J. 2007 Feb;21(2):393-401
17185749
EMBO J. 1991 Jul;10(7):1643-51
1828760
Science. 1985 Sep 27;229(4720):1402-5
2994223
J Acquir Immune Defic Syndr (1988). 1991;4(1):34-40
1984054
J Mol Biol. 2009 Jan 23;385(3):912-23
19007788
Biochim Biophys Acta. 2006 Jan;1758(1):111-23
16483537
Immunity. 1994 Aug;1(5):373-84
7882168
Proc Natl Acad Sci U S A. 1990 Jun;87(12):4650-4
2191297
Nat Med. 2003 Jul;9(7):853-60
12835705
Nat Rev Immunol. 2005 Oct;5(10):783-92
16200081
Nat Rev Immunol. 2003 Dec;3(12):973-83
14647479
Nat Med. 1997 Jan;3(1):84-8
8986747
Int Immunol. 1998 Apr;10(4):453-61
9620601
Science. 1992 Nov 6;258(5084):917-24
1439803
Proc Natl Acad Sci U S A. 1988 Apr;85(8):2444-8
3162770
J Virol. 2005 Apr;79(8):4720-9
15795258
Science. 1999 Nov 12;286(5443):1353-7
10558989
Nat Chem Biol. 2009 Apr;5(4):244-50
19234452
Biochemistry. 2008 Apr 22;47(16):4826-33
18376816
Cell. 1997 Apr 18;89(2):263-73
9108481
J Immunol. 2005 Nov 1;175(9):6050-7
16237100
J Immunol. 2000 Jul 15;165(2):663-70
10878338
Mol Membr Biol. 1999 Jan-Mar;16(1):3-9
10332732
J Immunol. 1990 May 15;144(10):3928-35
2139676
J Biol Chem. 2006 Jul 14;281(28):19618-30
16687395
J Mol Biol. 1970 Mar;48(3):443-53
5420325
Eur J Immunol. 1994 Jan;24(1):84-92
8020575
PLoS Pathog. 2009 Jul;5(7):e1000404
19649322
Cell Immunol. 1991 Oct 1;137(1):1-13
1832084
J Biol Chem. 1997 May 23;272(21):13496-505
9153194
J Virol. 1997 Mar;71(3):2041-9
9032336
Stat Med. 1990 Jul;9(7):811-8
2218183
J Virol. 1999 Aug;73(8):6430-5
10400736
Proc Natl Acad Sci U S A. 2000 Feb 1;97(3):1269-74
10655520
EMBO J. 2004 Jun 16;23(12):2348-57
15152191
Science. 1990 Jul 20;249(4966):274-7
2142801
Biochemistry. 1995 Oct 17;34(41):13390-7
7577925
Science. 2001 Aug 24;293(5534):1503-6
11520990
J Biol Chem. 2000 Aug 4;275(31):23602-7
10811807
J Virol. 2008 Jun;82(11):5417-28
18353944
Immunol Lett. 2006 Nov 15;107(2):89-92
16963128
Cell. 2002 Dec 27;111(7):967-79
12507424
Biochim Biophys Acta. 2004 Feb 10;1661(1):97-105
14967479
Biochim Biophys Acta. 2003 Jul 11;1614(1):122-9
12873773
J Clin Invest. 2005 Aug;115(8):2149-58
16007266
J Virol. 2002 Aug;76(15):7863-7
12097599
Biochim Biophys Acta. 2003 Jul 11;1614(1):36-50
12873764